Publicacions
-
Figuerola-Bou E, Rios-Astorch C, Blanco E, Sanchez-Jimenez M, Táboas-Outón P, Fernandez-Isern G, Gomez-Gonzalez S, Muñoz-Aznar O, Castellano-Escuder P, Pérez-Jaume S, Garcia-López M, Prada-Varela E, Mateo-Lozano S, Riggi N, Avgustinova A, Lavarino C, Di Croce L, Sánchez-Molina S and Mora J.
KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma.
CANCER RESEARCH . 85(22): 4485-4503.
-
Prada-Varela E, Táboas-Outón P, Andrades E, Gomez-Gonzalez S, Mateo-Lozano S, Cebrià A, Berenguer-Molins P, Perera-Bel J, Arcon JP, Saen-Oon S, Díaz L, Gay M, Folch-I-Casanovas I, Odena A, Vilaseca M, Rovira Q, García-Gerique L, Rodriguez E, Rovira-Zurriaga C, Rodrigues G, Carcaboso AM, Avgustinova A, Hernandez-Muñoz MI and Mora J.
PRKG1 hinders myogenic differentiation and predicts response to AKT inhibitor ipatasertib in Rhabdomyosarcoma.
NATURE COMMUNICATIONS . 16(1): 9816-9816.
-
Sentís I, Melero JL, Cebrià A, Grzelak M, Soto M, Michel A, Rovira Q, Rodriguez-Hernandez CJ, Caratù G, Urpi A, Sauvage C, Mendizabal-Sasieta A, Maspero D, Lavarino C, Pascual-Reguant A, Castañeda-Heredia A, Muñoz Perez JP, Mora J, Harari A, Nieto JC, Avgustinova A and Heyn H.
Spatiotemporal T-cell tracking for personalized T-cell receptor T-cell therapy designs in childhood cancer
ANNALS OF ONCOLOGY . 36(9): 1096-1106.
-
Lorito N, Subbiani A, Smiriglia A, Bacci M, Bonechi F, Tronci L, Romano E, Corrado A, Longo DL, Iozzo M, Ippolito L, Comito G, Giannoni E, Meattini I, Avgustinova A, Chiarugi P, Bachi A and Morandi A.
FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer
EMBO Molecular Medicine . 16(7): 1533-1559. Nº de cites: 42
-
Sanchez-Guixe E, Muiños F, Pinheiro-Santin M, González-Huici V, Rodriguez-Hernandez CJ, Avgustinova A, Lavarino C, González- Pérez A, Mora J and López-Bigas N.
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues
CANCER DISCOVERY . 14(6): 953-964. Nº de cites: 7
-
Llorente A, Blasco MT, Espuny I, Guiu M, Ballaré C, Blanco E, Caballé A, Bellmunt A, Salvador F, Morales A, Nuñez M, Loren G, Imbastari F, Fidalgo M, Figueras-Puig C, Gibler P, Graupera M, Monteiro F, Riera A, Holen I, Avgustinova A, Di Croce L and Gomis RR.
MAF amplification licenses ERa through epigenetic remodelling to drive breast cancer metastasis
NATURE CELL BIOLOGY . : 1833-1847. Nº de cites: 7
-
Figuerola-Bou E, Rios-Astorch C, Blanco E, Sanchez-Jimenez M, Táboas-Outón P, Fernandez-Isern G, Gomez-Gonzalez S, Muñoz-Aznar O, Castellano P, Pérez-Jaume S, Prada-Varela E, Mateo-Lozano S, Riggi N, Avgustinova A, Lavarino C, Di Croce L, Sánchez-Molina S and Mora J.
KDM6 demethylases mediate EWSR1-FLI1-driven oncogenic transformation in Ewing Sarcoma
Biorxiv . : .
-
Jenkins L, Jungwirth U, Avgustinova A, Iravani M, Mills AP, Haider S, Harper J and Isacke CM.
Cancer-Associated Fibroblasts Suppress CD8(+ )T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade
CANCER RESEARCH . 82(16): 2904-2917. Nº de cites: 160
-
Avgustinova A, Laudanna C, Pascual-García M, Rovira Q, Djurec M, Castellanos A, Urdiroz-Urricelqui U, Marchese D, Prats N, Van Keymeulen A, Heyn H, Vaquerizas JM and Benitah SA.
Repression of endogenous retroviruses prevents antiviral immune response and is required for mammary gland development.
Cell stem cell . 28(10): 1790. Nº de cites: 12
-
Avgustinova A, Symeonidi A, Castellanos A, Urdiroz-Urricelqui U, Solé-Boldo L, Martín M, Pérez-Rodríguez I, Prats N, Lehner B, Supek F and Benitah SA.
Loss of G9a preserves mutation patterns but increases chromatin accessibility, genomic instability and aggressiveness in skin tumours.
NATURE CELL BIOLOGY . 20(12): 1400-1409. Nº de cites: 34
